Germany Stem Cells Market Size & Outlook, 2025-2030
Global Market
Related Markets
Germany stem cells market highlights
- The Germany stem cells market generated a revenue of USD 933.3 million in 2024 and is expected to reach USD 1,591.4 million by 2030.
- The Germany market is expected to grow at a CAGR of 9.3% from 2025 to 2030.
- In terms of segment, adult stem cells was the largest revenue generating product in 2024.
- Induced Pluripotent Stem Cells is the most lucrative product segment registering the fastest growth during the forecast period.
Stem cells market data book summary
| Market revenue in 2024 | USD 933.3 million |
| Market revenue in 2030 | USD 1,591.4 million |
| Growth rate | 9.3% (CAGR from 2024 to 2030) |
| Largest segment | Adult stem cells |
| Fastest growing segment | Induced Pluripotent Stem Cells |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
| Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
Other key industry trends
- In terms of revenue, Germany accounted for 5.7% of the global stem cells market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany stem cells market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,261.7 million by 2030.
Germany has a large number of institutes and universities involved in stem cell research, thereby boosting revenue generation in this country. Moreover, conferences and workshops on human stem cell technology held in the region are expected to drive the regional market.
Although the country has strict laws and regulatory policies pertaining to stem cell research, the country encourages research in stem cells for clinical applications. AMESANAR is derived from allogeneic ABCB5-positive MSCs and will be produced by TICEBA GmbH from donor skin. Hence, it is one of the first somatic cell therapy based on skin validates to receive approval.
Advances in clinical applications of stem cell therapy along with growing preference for the therapy are expected to further influence the market growth. Increased adoption by the local population along with foreign patients visiting the country for stem cell therapies is anticipated to further boost the market growth.
No credit card required*
Publish Date: Feb 25, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Stem Cells Market Scope
Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Takara Bio Inc | View profile | 1,793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | www.takara-bio.co.jp |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | www.promocell.com/ |
| ATCC | View profile | 501-1000 | Manassas, Virginia, United States, North America | www.atcc.org/en.aspx |
| CellGenix | View profile | 51-100 | Freiburg, Baden-Wurttemberg, Germany, Europe | cellgenix.com |
| STEMCELL Technologies | View profile | 501-1000 | Vancouver, British Columbia, Canada, North America | www.stemcell.com |
Germany Stem Cells Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Stem Cells Market Outlook will help companies and investors design strategic landscapes.
Adult Stem Cells was the largest segment with a revenue share of 83.5% in 2024.
Horizon Databook has segmented the Germany stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Germany has a large number of institutes and universities involved in stem cell research, thereby boosting revenue generation in this country. Moreover, conferences and workshops on human stem cell technology held in the region are expected to drive the regional market.
Although the country has strict laws and regulatory policies pertaining to stem cell research, the country encourages research in stem cells for clinical applications. AMESANAR is derived from allogeneic ABCB5-positive MSCs and will be produced by TICEBA GmbH from donor skin. Hence, it is one of the first somatic cell therapy based on skin validates to receive approval.
Advances in clinical applications of stem cell therapy along with growing preference for the therapy are expected to further influence the market growth. Increased adoption by the local population along with foreign patients visiting the country for stem cell therapies is anticipated to further boost the market growth.
- Germany Stem Cells Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Expansion and Sub-Culture
- Cell Acquisition
- Cell Production
- Cryopreservation
- Germany Stem Cells Market Therapy Outlook (Revenue, USD Million , 2018-2030)
- Allogenic
- Autologous
- Germany Stem Cells Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Pharmaceutical and Biotechnology Companies
- Hospitals & Cell Banks
- Academic & Research Institutes
- Germany Stem Cells Market Product Outlook (Revenue, USD Million , 2018-2030)
- Adult Stem Cells
- Human Embryonic Stem Cells
- Very Small Embryonic Like Stem Cells
- Induced Pluripotent Stem Cells
- Germany Stem Cells Market Application Outlook (Revenue, USD Million , 2018-2030)
- Regenerative Medicine
- Drug Discovery and Development
Reasons to subscribe to Stem Cells Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Stem Cells Market Outlook databook
- Our clientele includes a mix of Stem Cells Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany Stem Cells Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany Stem Cells Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Germany Stem Cells Market, 2018-2030 (US$M)
Germany stem cells market statistics, by technology, 2018-2030 (US$M)
